Cargando…
Multidimensional phenotyping of the post‐COVID‐19 syndrome: A Swiss survey study
INTRODUCTION: Post‐COVID‐19 syndrome affects approximately 10–25% of people after a COVID‐19 infection, irrespective of initial COVID‐19 severity. The aim of this project was to assess the clinical characteristics, course, and prognosis of post‐COVID‐19 syndrome using a systematic multidimensional a...
Autores principales: | Diem, Lara, Schwarzwald, Anina, Friedli, Christoph, Hammer, Helly, Gomes‐Fregolente, Livia, Warncke, Jan, Weber, Lea, Kamber, Nicole, Chan, Andrew, Bassetti, Claudio, Salmen, Anke, Hoepner, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538958/ https://www.ncbi.nlm.nih.gov/pubmed/35975339 http://dx.doi.org/10.1111/cns.13938 |
Ejemplares similares
-
Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology,
Comorbidities and Association With Initial Course of COVID-19
por: Diem, Lara, et al.
Publicado: (2022) -
Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies
por: Friedli, Christoph, et al.
Publicado: (2021) -
Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients
por: Hammer, Helly, et al.
Publicado: (2022) -
Application of the “risk of ambulatory disability” (RoAD) score in a “real‐world” single‐center multiple sclerosis cohort
por: Pistor, Maximilian, et al.
Publicado: (2022) -
Vaccine Hesitancy in Patients With Multiple Sclerosis: Preparing for the SARS-CoV-2 Vaccination Challenge
por: Diem, Lara, et al.
Publicado: (2021)